Time to Culture Conversion of Bedaquiline and High-Dose Isoniazid for Drug-Resistant Tuberculosis. Academic Article uri icon

Overview

abstract

  • Patients with multidrug-resistant tuberculosis who received regimens containing high-dose isoniazid (INHHD) had similar time to culture conversion and treatment outcomes as patients who received regimens with bedaquiline. INHHD is an inexpensive and safe medication that may contribute additive efficacy in combination regimens.

publication date

  • August 29, 2022

Identity

PubMed Central ID

  • PMC9512704

Digital Object Identifier (DOI)

  • 10.1093/ofid/ofac440

PubMed ID

  • 36172057

Additional Document Info

volume

  • 9

issue

  • 9